A real world analysis of COVID-19 impact on hospitalizations in older adults with chronic conditions from an Italian region.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 08 2022
Historique:
received: 18 02 2022
accepted: 03 08 2022
entrez: 12 8 2022
pubmed: 13 8 2022
medline: 17 8 2022
Statut: epublish

Résumé

Healthcare delivery reorganization during the COVID-19 emergency may have had a significant impact on access to care for older adults with chronic conditions. We investigated such impact among all adults with chronic conditions aged ≥ 65 years, identified through the electronic health databases of two local health agencies-ATS Brianza and ATS Bergamo-from the Lombardy region, Italy. We considered hospitalizations for 2020 compared to the average 2017-2019 and quantified differences using rate ratios (RRs). Overall, in 2017-2019 there were a mean of 374,855 older adults with  ≥ 1 chronic condition per year in the two ATS and 405,371 in 2020. Hospitalizations significantly decreased from 84,624 (225.8/1000) in 2017-2019 to 78,345 (193.3/1000) in 2020 (RR 0.86). Declines were reported in individuals with many chronic conditions and for most Major Diagnostic Categories, except for diseases of the respiratory system. The strongest reductions were observed in hospitalizations for individuals with active tumours, particularly for surgical ones. Hospitalization rates increased in individuals with diabetes, likely due to COVID-19-related diseases. Although determinants of the decrease in demand and supply for care among chronic older adults are to be further explored, this raises awareness on their impacts on chronic patients' health in the medium and long run.

Identifiants

pubmed: 35962037
doi: 10.1038/s41598-022-17941-2
pii: 10.1038/s41598-022-17941-2
pmc: PMC9374749
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13704

Investigateurs

Cristina Bosetti (C)
Silvano Gallus (S)
Carlotta Micaela Jarach (CM)
Alessandra Lugo (A)
Chiara Stival (C)
Andrea Amerio (A)
Mario Amore (M)
Gianluca Serafini (G)
Roberto De Sena (R)
Simone Ghislandi (S)
David Stuckler (D)
Yuxi Wang (Y)
Marialaura Bonaccio (M)
Francesco Gianfagna (F)
Licia Iacoviello (L)
Giansanto Mosconi (G)
Anna Odone (A)
Carlo Signorelli (C)
Giacomo Vigezzi (G)
Luca Cavalieri d'Oro (LC)
Luca Paroni (L)
Marco Sala (M)
Magda Rognoni (M)
Roberta Ciampichini (R)
Alberto Zucchi (A)

Informations de copyright

© 2022. The Author(s).

Références

Infect Genet Evol. 2021 Jan;87:104647
pubmed: 33264669
Acta Biomed. 2020 Jul 20;91(9-S):34-39
pubmed: 32701915
Ann Oncol. 2020 Aug;31(8):1065-1074
pubmed: 32442581
PLoS One. 2021 Mar 22;16(3):e0248995
pubmed: 33750990
Aging Clin Exp Res. 2020 Jul;32(7):1189-1194
pubmed: 32458356
Lancet Reg Health Eur. 2021 Mar 02;3:100055
pubmed: 34557800
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Public Health. 2021 Sep;198:85-88
pubmed: 34365111
Am J Clin Pathol. 2021 Jan 4;155(1):64-68
pubmed: 32995855
Fam Pract. 2022 Jul 19;39(4):747-761
pubmed: 34611708
Front Public Health. 2021 Mar 16;9:650243
pubmed: 33796500
Clin Cardiol. 2020 Oct;43(10):1142-1149
pubmed: 32691901
JAMA Intern Med. 2021 Feb 1;181(2):269-271
pubmed: 33104158
Int J Public Health. 2020 Nov;65(8):1435-1436
pubmed: 32978645
N Engl J Med. 2020 Jul 2;383(1):88-89
pubmed: 32343497
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
J Public Health Policy. 2020 Sep;41(3):238-244
pubmed: 32472024
Am J Clin Oncol. 2020 Jun;43(6):452-455
pubmed: 32304435
Arch Acad Emerg Med. 2020 Mar 24;8(1):e35
pubmed: 32232218
JAMA Intern Med. 2021 Feb 1;181(2):272-274
pubmed: 33104161
Risk Manag Healthc Policy. 2021 Feb 15;14:575-584
pubmed: 33623448
Environ Res. 2021 Feb;193:110476
pubmed: 33221311
N Engl J Med. 2020 Oct 8;383(15):1483-1488
pubmed: 32706956
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
BMJ. 2021 May 24;373:n1135
pubmed: 34035000
PLoS One. 2021 Jun 1;16(6):e0252441
pubmed: 34061888
BMJ Open. 2021 Mar 16;11(3):e045343
pubmed: 33727273
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):965-967
pubmed: 32604016
Nephrology (Carlton). 2022 May;27(5):410-420
pubmed: 34921475
Lancet Public Health. 2020 Oct;5(10):e536-e542
pubmed: 32950075

Auteurs

Cristina Bosetti (C)

Department of Oncology, Laboratory of Methodology for Clinical Research, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy. cristina.bosetti@marionegri.it.

Magda Rognoni (M)

Epidemiology Unit, Agenzia per la Tutela della Salute della Brianza, Monza, Italy.

Roberta Ciampichini (R)

Agenzia per la Tutela della Salute di Bergamo, Bergamo, Italy.

Luca Paroni (L)

Epidemiology Unit, Agenzia per la Tutela della Salute della Brianza, Monza, Italy.

Marco Scala (M)

Epidemiology Unit, Agenzia per la Tutela della Salute della Brianza, Monza, Italy.

Luca Cavalieri d'Oro (LC)

Epidemiology Unit, Agenzia per la Tutela della Salute della Brianza, Monza, Italy.

Alberto Zucchi (A)

Agenzia per la Tutela della Salute di Bergamo, Bergamo, Italy.

Andrea Amerio (A)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, Università di Genova, Genoa, Italy.
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Licia Iacoviello (L)

Research Center in Epidemiology and Preventive Medicine (EPIMED), Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Italy.

Simone Ghislandi (S)

Department of Social Sciences and Politics, Bocconi University, Milan, Italy.

Anna Odone (A)

School of Medicine, University Vita-Salute San Raffaele, Milan, Italy.
Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.

David Stuckler (D)

Department of Social Sciences and Politics, Bocconi University, Milan, Italy.

Silvano Gallus (S)

Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH